8-K
filed May 29, 2026, 5:00 PM ET
ticker SCNX
CIK 0001382574
leadership
confidence high
sentiment neutral
materiality 0.55
Scienture CFO Eric Sherb resigns; co-CEO Narasimhan Mani named interim CFO
Scienture Holdings, Inc.
- Eric Sherb resigned as CFO effective May 26, 2026; cited personal reasons, no disagreement with management or board.
- Dr. Narasimhan Mani appointed Interim CFO same day; Mani also serves as co-CEO, President, and director.
- Mani holds an MBA in Finance from Columbia Business School and has 25+ years in pharma leadership roles.
- No material transaction or family relationship between Mani and the company; employment governed by existing agreement.
- Mani previously served as CEO of Kesin Pharma and Xiromed, and VP strategy at Amneal Pharmaceuticals.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-026414
- form_type
- 8-K
- ticker
- SCNX
- cik
- 0001382574
- company_name
- Scienture Holdings, Inc.
- filed_at
- 2026-05-29T21:00:24+00:00
- discovered_at
- 2026-05-29T21:02:00.275367+00:00
- generated_at
- 2026-05-29T21:02:52.947674+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.55
- calibrated_materiality_score
- 0.55
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-026414
- json_url
- https://secwatch.observer/filing/0001493152-26-026414.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-026414.md
- text_url
- https://secwatch.observer/filing/0001493152-26-026414.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
Federal Home Loan Bank of Pittsburgh
FHLB Pittsburgh CFO Edward V. Weller to retire on Oct 20, 2026
Federal Home Loan Bank of Pittsburgh
June 1, 2026, 3:08 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
On May 28, 2026, the Federal Home Loan Bank of Pittsburgh (Bank) received notice from Edward V. Weller, Chief Financial Officer, of his intent to retire from the Bank on or about October 20, 2026.
Filing page
SEC filing
MGNO
Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair
Magnolia Bancorp, Inc.
June 1, 2026, 2:15 PM ET
leadership
Items 5.02, 5.07, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.
Filing page
SEC filing
FSBW
FS Bancorp names Matt Mullet CEO as planned; Joe Adams retires but stays on board
FS Bancorp, Inc.
June 1, 2026, 11:31 AM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
it has named Matthew D. Mullet as Chief Executive Officer of the Company effective June 1, 2026
Filing page
SEC filing
RVRC
Revium Rx CFO Arie Gordashnikov resigns; Igor Bluvstein appointed effective May 27, 2026
Revium Rx.
June 1, 2026, 9:58 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.
Filing page
SEC filing
NSC
Norfolk Southern COO John Orr resigns; Brian Barr appointed successor effective June 1
NORFOLK SOUTHERN CORP
June 1, 2026, 9:15 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
On May 31, 2026, John Orr, Executive Vice President & Chief Operating Officer of Norfolk Southern Corporation (the “Company”), notified the Company of his intention to resign from the Company for “good reason” on account of proposed changes in the Company’s operations that would result in a diminution of his duties and responsibilities.
Filing page
SEC filing
BTBD
BT Brands CFO Kenneth Brimmer resigns; no successor named
BT Brands, Inc.
June 1, 2026, 8:56 AM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
Effective May 26, 2026, Kenneth Brimmer resigned from his positions as a member of the Board of Directors and Chief Financial Officer of BT Brands, Inc.
Filing page
SEC filing
FUSE
Fusemachines appoints AI pioneer Dr. Julia Hirschberg to board; Shrestha resigns
Fusemachines Inc.
June 1, 2026, 8:18 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
Effective May 31, 2026, the board of directors (the “Board”) of Fusemachines Inc., a Delaware corporation (the “Company” or “Fusemachines”), following the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Julia Hirschberg as a member of the Board as a Class II director, until the Company’s 2027 annual meeting of stockholders or until Ms. Hirschberg’s successor is duly elected and qualified.
Filing page
SEC filing
SNDA
Sonida Senior Living appoints Anton Nikodemus as COO effective June 15, 2026; base salary $550,000
SONIDA SENIOR LIVING, INC.
June 1, 2026, 8:09 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
the Company appointed Dr. Narasimhan Mani (age 51) to serve as the Company’s Interim Chief Financial Officer ("Interim CFO") effective as of May 26, 2026.
Comparable filing
On June 1, 2026, the Board of Directors (the “Board”) of Sonida Senior Living, Inc. (the “Company”) appointed Anton Nikodemus as Executive Vice President and Chief Operating Officer of the Company, effective June 15, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.